Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does LIPOSOMAL DOXORUBICIN Cause Flushing? 6 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Flushing have been filed in association with LIPOSOMAL DOXORUBICIN. This represents 31.6% of all adverse event reports for LIPOSOMAL DOXORUBICIN.

6
Reports of Flushing with LIPOSOMAL DOXORUBICIN
31.6%
of all LIPOSOMAL DOXORUBICIN reports
0
Deaths
2
Hospitalizations

How Dangerous Is Flushing From LIPOSOMAL DOXORUBICIN?

Of the 6 reports, 2 (33.3%) required hospitalization.

Is Flushing Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for LIPOSOMAL DOXORUBICIN. However, 6 reports have been filed with the FAERS database.

What Other Side Effects Does LIPOSOMAL DOXORUBICIN Cause?

Dyspnoea (5) Infusion related reaction (5)

What Other Drugs Cause Flushing?

DIMETHYL (10,681) TREPROSTINIL (3,166) TECFIDERA (2,385) AMBRISENTAN (1,741) DALFAMPRIDINE (1,605) DIROXIMEL (1,518) INFLIXIMAB (1,488) PACLITAXEL (1,397) GLATIRAMER (1,291) EPOPROSTENOL (1,256)

Related Pages

LIPOSOMAL DOXORUBICIN Full Profile All Flushing Reports All Drugs Causing Flushing LIPOSOMAL DOXORUBICIN Demographics